Unknown

Dataset Information

0

Donor Heart Preservation with Hydrogen Sulfide: A Systematic Review and Meta-Analysis.


ABSTRACT: Preclinical studies have shown that postconditioning with hydrogen sulfide (H2S) exerts cardioprotective effects against myocardial ischemia-reperfusion injury (IRI). The aim of this study was to appraise the current evidence of the cardioprotective effects of H2S against IRI in order to explore the future implementation of H2S in clinical cardiac transplantation. The current literature on H2S postconditioning in the setting of global myocardial ischemia was systematically reviewed and analyzed, performing meta-analyses. A literature search of the electronic databases Medline, Embase and Cinahl identified 1835 studies that were subjected to our pre-defined inclusion criteria. Sixteen studies were considered eligible for inclusion. Postconditioning with H2S showed significant robust effects with regard to limiting infarct size (standardized mean difference (SMD) = -4.12, 95% CI [-5.53--2.71], p < 0.00001). Furthermore, H2S postconditioning consistently resulted in a significantly lower release of cardiac injury markers, lower levels of oxidative stress and improved cardiac function. Postconditioning with slow-releasing H2S donors offers a valuable opportunity for novel therapies within cardiac preservation for transplantation. Before clinical implication, studies evaluating the long-term effects of H2S treatment and effects of H2S treatment in large animal studies are warranted.

SUBMITTER: Ertugrul IA 

PROVIDER: S-EPMC8198118 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Donor Heart Preservation with Hydrogen Sulfide: A Systematic Review and Meta-Analysis.

Ertugrul Imran A IA   van Suylen Vincent V   Damman Kevin K   de Koning Marie-Sophie L Y MLY   van Goor Harry H   Erasmus Michiel E ME  

International journal of molecular sciences 20210527 11


Preclinical studies have shown that postconditioning with hydrogen sulfide (H<sub>2</sub>S) exerts cardioprotective effects against myocardial ischemia-reperfusion injury (IRI). The aim of this study was to appraise the current evidence of the cardioprotective effects of H<sub>2</sub>S against IRI in order to explore the future implementation of H<sub>2</sub>S in clinical cardiac transplantation. The current literature on H<sub>2</sub>S postconditioning in the setting of global myocardial ischem  ...[more]

Similar Datasets

| S-EPMC5730622 | biostudies-literature
| 79216 | ecrin-mdr-crc
| S-EPMC6022369 | biostudies-literature
| S-EPMC8300844 | biostudies-literature
| S-EPMC8454909 | biostudies-literature
| S-EPMC8983812 | biostudies-literature
| S-EPMC9247975 | biostudies-literature
| S-EPMC4395833 | biostudies-other
| S-EPMC2596495 | biostudies-other
| 2654299 | ecrin-mdr-crc